https://www.selleckchem.com/pr....oducts/1-naphthyl-pp
The UK has implemented routine use of whole genome sequencing (WGS)in TB diagnostics. The WHO recommends addition of a fluoroquinolone for isoniazid mono-resistance, so early detection may be of use. The aim of this study was to describe the clinical utility and impact of WGS on treatment decisions for TB in a low incidence high resource clinical setting. The clinical turnaround time (TAT)for WGS was analysed in comparison to TB PCR using Xpert MTB/RIF (Cepheid, Sunnyvale, CA) results where available and subsequent
Curtir
Comentario
Compartilhar
